Therapeutic discovery begins with sound experimental design, detailing the precise clinical biospecimens vital for revealing microbiome-generated bioactives. We collect those biospecimens in our patient-friendly kits to ensure excellent preservation and efficient shipping to our laboratory in South San Francisco. Our propitiatory TracerMix™ reagents allows high-throughput quantitative sample handling and eliminates unreproducible results often “discovered” in big data. Samples then proceed through the first and only metagenomic platform to employ multiple confirmatory assays, leveraging both NGS and PhyloChip™ to identify and quantify the microbiome products that differentiate the disease state from the healthy state in the tissue under investigation.